This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Tosoh Corporation. Active years: 1990-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ebina, JP (1990)
- Ayase, JP (2018)
Company Filing History:
Years Active: 1990-2018
Title: Koji Shintani: Innovator in Immunological Assays
Introduction
Koji Shintani is a notable inventor based in Ayase, Japan. He has made significant contributions to the field of immunological assays, holding a total of 2 patents. His work focuses on improving the accuracy and efficiency of immunological testing methods.
Latest Patents
Shintani's latest patents include an innovative immunological assay method. This method addresses the challenge of uniformly immobilizing a substance equivalent to an antigen on a solid phase. The solution involves measuring an analyte substance in a sample by using an equivalent substance that is immunologically equivalent to the analyte. This equivalent substance is immobilized on a solid phase through a bond with a carrier substance, which does not bind to the labeled antibody. Additionally, he has developed a method for removing pyrogens from pyrogen-containing sample solutions. This method involves adding a calcium salt to the sample solution and separating the resulting precipitates.
Career Highlights
Koji Shintani is currently employed at Tosoh Corporation, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the reliability of immunological assays, which are crucial in various medical and research applications.
Collaborations
Shintani collaborates with esteemed colleagues, including Kazuhide Yoshikawa and Hiroshi Iida. Their combined expertise contributes to the innovative projects at Tosoh Corporation.
Conclusion
Koji Shintani's contributions to immunological assays exemplify the impact of dedicated inventors in the field of biotechnology. His patents reflect a commitment to improving testing methods, ultimately benefiting the medical community and research institutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
